Limburg Ventures

Limburg Ventures is a venture capital fund that invests in startups in life sciences and related fields of advanced chemicals and materials.

Business Model:

Revenue: $37.4M

Employees: 201-500

Rankings

Detailed Limburg Ventures Information

Geographic Data

Limburg Ventures headquarters map

Address: Boschstraat 76

City: Maastricht

State: limburg

Zip: 6122

Country: NL

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Limburg Ventures is a private equity firm focuses on startup, early, mid venture, late venture and buyout investments.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
2/2015 FABPulous Series B 0
1/2009 Chemtrix Venture Round -
1/2006 Polyscope Polymers Funding Round -
10/2010 CellMade Funding Round 2.3M
5/2011 ACS Biomarker Venture Round -
1/2010 FABPulous Series A -
3/2013 Ekompany Venture Round 0
1/2012 Mirnext Venture Round -
7/2011 BioActor Series A 0
6/2004 Fortimedix Venture Round -
5/2011 Q Chip Series C 0
2/2011 Nano4Imaging Venture Round -
1/2014 Enzypep Funding Round -
9/2017 Kriya Materials Series A 0
11/2005 Basic Pharma Venture Round -
4/2004 Cilian AG Series B 6.1M
2/2011 MagnaMedics Series B -
6/2009 TiGenix Private Equity Round 7.5M
2/2007 PharmaCell Venture Round 2.6M
1/2008 MagnaMedics Funding Round -
1/2008 Isobionics Funding Round -
9/2017 Kriya Materials Series A 0
2/2015 FABPulous Series B 0
1/2014 Enzypep Funding Round -
3/2013 Ekompany Venture Round 0
1/2012 Mirnext Venture Round -
7/2011 BioActor Series A 0
5/2011 Q Chip Series C 0
5/2011 ACS Biomarker Venture Round -
2/2011 Nano4Imaging Venture Round -
2/2011 MagnaMedics Series B -

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research